Aspirin: Difference between revisions

Content deleted Content added
rank
m Duplicate word removed
 
(18 intermediate revisions by 10 users not shown)
Line 84:
| NIAID_ChemDB =
| PDB_ligand = AIN
| synonyms = {{ubl|2-acetoxybenzoic acid|''o''-acetylsalicylic acid|acetylsalicylic acid|acetyl salicylate|monoacetic acid ester of salicylic acid<ref>{{cite journal|journal=Bulletin of the History of Medicine|title=What's in a Name? Aspirin and the American Medical Association|first=Jan|last vauthors = McTavish J |volume=61|number=3|date=Fall 1987|pages=343–366 |jstor=44442097 |pmid=3311247 |url=https://www.jstor.org/stable/44442097}}</ref>}}
 
<!-- Chemical and physical data -->
Line 109:
}}
 
'''Aspirin''', also known as '''acetylsalicylic acid''' ('''ASA'''), is a [[nonsteroidal anti-inflammatory drug]] (NSAID) used to reduce [[pain]], [[fever]], and/or [[inflammation]], and as an [[antithrombotic]].<ref name=AHFS>{{cite web|title=Aspirin|url=https://www.drugs.com/monograph/aspirin.html|via=Drugs.com|publisher=[[American Society of Health-System Pharmacists]]|date=29 November 2021|url-status=live|archive-url=https://web.archive.org/web/20170425142242/https://www.drugs.com/monograph/aspirin.html|archive-date=25 April 2017}}</ref> Specific inflammatory conditions whichthat aspirin is used to treat include [[Kawasaki disease]], [[pericarditis]], and [[rheumatic fever]].<ref name=AHFS/>
 
Aspirin is also used long-term to help prevent further [[heart attacks]], [[ischaemic stroke]]s, and [[thrombus|blood clots]] in people at high risk.<ref name=AHFS/> For pain or fever, effects typically begin within 30 minutes.<ref name=AHFS/> Aspirin works similarly to other NSAIDs but also suppresses the normal functioning of [[platelet]]s.<ref name=AHFS/>
Line 115:
One common [[adverse effect]] is an [[upset stomach]].<ref name=AHFS/> More significant side effects include [[stomach ulcer]]s, [[stomach bleeding]], and worsening [[asthma]].<ref name=AHFS/> Bleeding risk is greater among those who are older, drink [[Alcohol (drug)|alcohol]], take other NSAIDs, or are on other [[anticoagulant|blood thinners]].<ref name=AHFS/> Aspirin is not recommended in the last part of [[pregnancy]].<ref name=AHFS/> It is not generally recommended in children with [[infection]]s because of the risk of [[Reye syndrome]].<ref name=AHFS/> High doses may result in [[tinnitus|ringing in the ears]].<ref name=AHFS/>
 
A [[Precursor (chemistry)|precursor]] to aspirin found in the bark of the [[willow tree]] (genus ''Salix'') has been used for its health effects for at least 2,400 years.<ref name=Jon2015>{{cite book |vauthors = Jones A |title=Chemistry: An Introduction for Medical and Health Sciences|date=2015|publisher=John Wiley & Sons|isbn=978-0-470-09290-3|pages=5–6|url=https://books.google.com/books?id=ubE0ILq_aDQC&pg=PA6}}</ref><ref>{{cite book |vauthors = Ravina E |title=The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs |date=2011 |publisher=John Wiley & Sons |isbn=978-3-527-32669-3 |page=24 |url=https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA24}}</ref> In 1853, chemist [[Charles Frédéric Gerhardt]] treated the medicine [[sodium salicylate]] with [[acetyl chloride]] to produce acetylsalicylic acid for the first time.<ref name="Jeffreys2008">{{cite book |url=https://books.google.com/books?id=a9gkBwAAQBAJ |title=Aspirin the remarkable story of a wonder drug. |vauthors=Jeffreys D |date=2008 |publisher=Bloomsbury Publishing USA |isbn=978-1-59691-816-0 |archive-url=https://web.archive.org/web/20170908213430/https://books.google.com/books?id=a9gkBwAAQBAJ |archive-date=8 September 2017 |url-status=}}{{rp|46–48}}</ref> Over the next 50 years, other chemists, mostly of the German company [[Bayer]], established the chemical structure and devised more efficient production methods.<ref name=Jeffreys2008/>{{rp|69–75}} [[Felix Hoffmann]] (or [[Arthur Eichengrün]]) of Bayer was the first to produce acetylsalicylic acid in a pure, stable form in 1897.<ref name=HoffmannSHI>{{Cite web |title=Felix Hoffmann |url=https://www.sciencehistory.org/education/scientific-biographies/felix-hoffmann/ |access-date=3 October 2024 |publisher=[[Science History Institute]]}}</ref> By 1899, Bayer had dubbed this drug Aspirin and was selling it globally.<ref name=MannPlummer1991/>{{rp|27}}
 
Aspirin is available [[Over-the-counter drug|without medical prescription]] as a proprietary or [[generic medication]]<ref name=AHFS/> in most jurisdictions. It is one of the most widely used medications globally, with an estimated {{convert|40000|tonne}} (50 to 120 billion [[Tablet (pharmacy)|pills]]) consumed each year,<ref name="Jon2015" /><ref name="COX2002">{{cite journal|vauthors=Warner TD, Mitchell JA|date=October 2002|title=Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?|journal=Proceedings of the National Academy of Sciences of the United States of America|volume=99|issue=21|pages=13371–3|bibcode=2002PNAS...9913371W|doi=10.1073/pnas.222543099 |pmc=129677|pmid=12374850|doi-access=free | title-link = doi }}</ref> and is on the [[WHO Model List of Essential Medicines|World Health Organization's List of Essential Medicines]].<ref name="WHO23rd">{{cite book | vauthors = ((World Health Organization)) | title = The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023) | year = 2023 | hdl = 10665/371090 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MHP/HPS/EML/2023.02 | hdl-access=free }}</ref> In 2022, it was the 36th most commonly prescribed medication in the United States, with more than 16{{nbsp}}million prescriptions.<ref>{{cite web | title=The Top 300 of 2022 | url=https://clincalc.com/DrugStats/Top300Drugs.aspx | website=ClinCalc | access-date=30 August 2024 | archive-date=30 August 2024 | archive-url=https://web.archive.org/web/20240830202410/https://clincalc.com/DrugStats/Top300Drugs.aspx | url-status=live }}</ref><ref>{{cite web | title = Aspirin Drug Usage Statistics, United States, 2013 - 2022 | website = ClinCalc | url = https://clincalc.com/DrugStats/Drugs/Aspirin | access-date = 30 August 2024 }}</ref>
Line 122:
In 1897, scientists at the [[Bayer]] company began studying acetylsalicylic acid as a less-irritating replacement medication for common salicylate medicines.<ref name=Jeffreys2008/>{{rp|69–75}}<ref name="Distillations">{{cite magazine | vauthors = Dick B |title=Hard Work and Happenstance |url=https://www.sciencehistory.org/distillations/magazine/hard-work-and-happenstance |magazine=Distillations |publisher=[[Science History Institute]] |date=2018 |volume=4 |issue=1 |pages=44–45 }}</ref> By 1899, Bayer had named it "Aspirin" and was selling it around the world.<ref name=MannPlummer1991>{{cite book | vauthors = Mann CC, Plummer ML |title=The aspirin wars: money, medicine, and 100 years of rampant competition |date=1991 |publisher=Knopf |location=New York |isbn=978-0-394-57894-1 |page=[https://archive.org/details/aspirinwarsmoney1991mann/page/27 27] |edition=1st |url=https://archive.org/details/aspirinwarsmoney1991mann/page/27}}</ref>
 
Aspirin's popularity grew over the first half of the 20th century, leading to competition between many brands and formulations.<ref name="ACS">{{cite magazine |title=Aspirin |magazine=Chemical & Engineering News |date=20 June 2005 |volume=83 |issue=25 |url=https://pubsapp.acs.org/cen/coverstory/83/8325/8325aspirin.html }}</ref> The word ''Aspirin'' was Bayer's brand name; however, theirits rights to the [[trademark]] were [[Generic trademark|lost or sold in many countries]].<ref name=ACS/> The name is ultimately a blend of the prefix '''a'''(cetyl) + '''spir''' ''[[Spiraea]]'', the meadowsweet plant genus from which the acetylsalicylic acid was originally derived at Bayer + '''-in''', the common chemical suffix.{{Citation needed|date=April 2024}}
 
==Chemical properties==
Line 140:
 
==Physical properties==
Aspirin, an [[acetyl]] derivative of salicylic acid, is a white, crystalline, weakly acidic substance, whichthat melts at {{convert|136|C|F}},<ref name=b92>{{RubberBible92nd|page=3.8}}</ref> and decomposes around {{convert|140|C|F}}.<ref name="Myers2007">{{cite book |vauthors=Myers RL |title=The 100 most important chemical compounds: a reference guide |url=https://books.google.com/books?id=MwpQWcIKMzAC&pg=PA10 |year=2007 |publisher=ABC-CLIO |isbn=978-0-313-33758-1 |page=10 |url-status=live |archive-url=https://web.archive.org/web/20130610170345/http://books.google.com/books?id=MwpQWcIKMzAC&pg=PA10 |archive-date=10 June 2013}}</ref> Its [[acid dissociation constant]] (p''K''<sub>a</sub>) is 3.5 at {{convert|25|C|F}}.<ref name="asaaciddissconst">{{cite web |title=Acetylsalicylic acid |publisher=Jinno Laboratory, School of Materials Science, Toyohashi University of Technology |date=4 March 1996 |url=http://chrom.tutms.tut.ac.jp/JINNO/DRUGDATA/07acetylsalicylic_acid.html |access-date=12 April 2014 |url-status=dead |archive-url=https://web.archive.org/web/20120120224558/http://chrom.tutms.tut.ac.jp/JINNO/DRUGDATA/07acetylsalicylic_acid.html |archive-date=20 January 2012}}</ref>
 
===Polymorphism===
Line 146:
[[Polymorphism (materials science)|Polymorphism]], or the ability of a substance to form more than one [[crystal structure]], is important in the development of pharmaceutical ingredients. Many drugs receive regulatory approval for only a single crystal form or polymorph.
 
ThereUntil 2005, there was only one proven polymorph of aspirin ('''Form I''' of aspirin), though the existence of another polymorph was debated since the 1960s, and one report from 1981 reported that when crystallized in the presence of aspirin ''anhydride'', the [[diffractogram]] of aspirin has weak additional peaks. Though at the time it was dismissed as mere impurity, it was, in retrospect, '''Form II''' aspirin.<ref name="Bučar-2015">{{cite journal | vauthors = Bučar DK, Lancaster RW, Bernstein J | title = Disappearing polymorphs revisited | journal = Angewandte Chemie | volume = 54 | issue = 24 | pages = 6972–6993 | date = June 2015 | pmid = 26031248 | pmc = 4479028 | doi = 10.1002/anie.201410356 }}</ref>
 
'''Form II''' was reported in 2005,<ref>{{cite journal | vauthors = Vishweshwar P, McMahon JA, Oliveira M, Peterson ML, Zaworotko MJ | title = The predictably elusive form II of aspirin | journal = Journal of the American Chemical Society | volume = 127 | issue = 48 | pages = 16802–16803 | date = December 2005 | pmid = 16316223 | doi = 10.1021/ja056455b }}</ref><ref>{{cite journal | vauthors = Bond AD, Boese R, Desiraju GR | title = On the polymorphism of aspirin: crystalline aspirin as intergrowths of two "polymorphic" domains | journal = Angewandte Chemie | volume = 46 | issue = 4 | pages = 618–622 | year = 2007 | pmid = 17139692 | doi = 10.1002/anie.200603373 }}</ref> found after attempted co-crystallization of aspirin and [[levetiracetam]] from hot [[acetonitrile]].
Line 153:
 
Pure Form II aspirin could be prepared by seeding the batch with aspirin anhydrate in 15% weight.<ref name="Bučar-2015" />
 
Form III was reported in 2015 by compressing form I above 2 GPa, but it reverts back to Form I when pressure is removed.<ref>{{Cite journal | vauthors = Crowell EL, Dreger ZA, Gupta YM |date=2015-02-15 |title=High-pressure polymorphism of acetylsalicylic acid (aspirin): Raman spectroscopy |url=https://www.sciencedirect.com/science/article/abs/pii/S0022286014011065 |journal=Journal of Molecular Structure |volume=1082 |pages=29–37 |doi=10.1016/j.molstruc.2014.10.079 |issn=0022-2860}}</ref> Form IV was reported in 2017. It is stable at ambient conditions.<ref>{{Cite journal | vauthors = Shtukenberg AG, Hu CT, Zhu Q, Schmidt MU, Xu W, Tan M, Kahr B |date=2017-06-07 |title=The Third Ambient Aspirin Polymorph |url=https://pubs.acs.org/doi/10.1021/acs.cgd.7b00673 |journal=Crystal Growth & Design |language=en |volume=17 |issue=6 |pages=3562–3566 |doi=10.1021/acs.cgd.7b00673 |issn=1528-7483}}</ref>
 
==Mechanism of action==
Line 203 ⟶ 205:
[[File:Aspirine-1923.jpg|thumb|left|1923 advertisement]]
<!-- DO NOT PUT NEW CONTENT HERE. PLEASE UPDATE THE BODY OF [[HISTORY OF ASPIRIN]] AND UPDATE THE LEAD, AND COPY THAT LEAD HERE -->
Medicines made from [[willow]] and other [[salicylate]]-rich plants appear in clay tablets from ancient [[Sumer]] as well as the [[Ebers Papyrus]] from ancient Egypt.<ref name=Jeffreys2008/>{{rp|8–13}}<ref name=ACS/> Hippocrates referred to the use of salicylic tea to reduce fevers around 400 BC, and willow bark preparations were part of the pharmacopoeia of Western medicine in [[classical antiquity]] and the [[Middle Ages]].<ref name=ACS/> Willow bark extract became recognized for its specific effects on fever, pain, and inflammation in the mid-eighteenth century.<ref name="Goldberg">{{cite magazine |vauthors = Goldberg DR |title=Aspirin: Turn of the Century Miracle Drug|url=https://www.sciencehistory.org/distillations/magazine/aspirin-turn-of-the-century-miracle-drug|magazine=Chemical Heritage |date=Summer 2009|volume=27|issue= 2|pages=26–30}}</ref> after the Rev Edward Stone of [[Chipping Norton]], Oxfordshire, noticed that the bitter taste of willow bark resembled the taste of the bark of the [[cinchona]] tree, known as "[[Peruvian bark]]", which was used successfully in [[Peru]] to treat a variety of ailments. Stone experimented with preparations of powdered willow bark on people in Chipping Norton for five years and found it to be as effective as Peruvian bark and a cheaper domestic version. In 1763 he sent a report of his findings to the [[Royal Society]] in London.<ref>{{cite book|title= Aspirin: the Remarkable Story of a Wonder Drug |author= Diarmuid Jeffreys |publisher=Bloomsbury |date=2004 |page=18-34 }}</ref> By the nineteenth century, pharmacists were experimenting with and prescribing a variety of chemicals related to [[salicylic acid]], the active component of willow extract.<ref name="Jeffreys2008" />{{rp|46–55}}
 
[[File:Old Package of Aspirin.jpg|thumb|Old package. "Export from Germany is prohibited"]]
In 1853, chemist [[Charles Frédéric Gerhardt]] treated [[sodium salicylate]] with [[acetyl chloride]] to produce acetylsalicylic acid for the first time;<ref name=Jeffreys2008/>{{rp|46–48}} in the second half of the 19th century, other academic chemists established the compound's chemical structure and devised more efficient methods of synthesis. In 1897, scientists at the drug and dye firm [[Bayer]] began investigating acetylsalicylic acid as a less-irritating replacement for standard common salicylate medicines, and identified a new way to synthesize it.<ref name=Jeffreys2008/>{{rp|69–75}} That year, [[Felix Hoffmann]] (or [[Arthur Eichengrün]]) of Bayer was the first to produce acetylsalicylic acid in a pure, stable form.<ref name=HoffmannSHI /> By 1899, Bayer had dubbed this drug Aspirin and was selling it globally.<ref name=MannPlummer1991/>{{rp|27}} The word ''Aspirin'' was Bayer's brand name, rather than the generic name of the drug; however, Bayer's rights to the trademark were lost or sold in many countries. Aspirin's popularity grew over the first half of the 20th century leading to fierce competition with the proliferation of aspirin brands and products.<ref name=ACS/>
 
Aspirin's popularity declined after the development of [[paracetamol|acetaminophen/paracetamol]] in 1956 and [[ibuprofen]] in 1962. In the 1960s and 1970s, [[John Vane]] and others discovered the basic mechanism of aspirin's effects,<ref name=Jeffreys2008/>{{rp|226–231}} while clinical trials and other studies from the 1960s to the 1980s established aspirin's efficacy as an anti-clotting agent that reduces the risk of clotting diseases.<ref name=Jeffreys2008/>{{rp|247–257}} The initial large studies on the use of low-dose aspirin to prevent heart attacks that were published in the 1970s and 1980s helped spur reform in [[clinical research ethics]] and [[guidelines for human subject research]] and US federal law, and are often cited as examples of clinical trials that included only men, but from which people drew general conclusions that did not hold true for women.<ref>{{cite journal | vauthors = Schiebinger L | title = Women's health and clinical trials | journal = The Journal of Clinical Investigation | volume = 112 | issue = 7 | pages = 973–7 | date = October 2003 | pmid = 14523031 | pmc = 198535 | doi = 10.1172/JCI19993 }}</ref><ref>{{cite journal | vauthors = | title = Regular aspirin intake and acute myocardial infarction | journal = British Medical Journal | volume = 1 | issue = 5905 | pages = 440–3 | date = March 1974 | pmid = 4816857 | pmc = 1633212 | doi = 10.1136/bmj.1.5905.440 }}</ref><ref>{{cite journal | vauthors = Elwood PC, Cochrane AL, Burr ML, Sweetnam PM, Williams G, Welsby E, Hughes SJ, Renton R | title = A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction | journal = British Medical Journal | volume = 1 | issue = 5905 | pages = 436–40 | date = March 1974 | pmid = 4593555 | pmc = 1633246 | doi = 10.1136/bmj.1.5905.436 }}</ref>
Line 243 ⟶ 245:
 
===Fever===
Like its ability to control pain, aspirin's ability to control [[fever]] is due to its action on the [[prostaglandin]] system through its irreversible inhibition of [[COX]].<ref>{{cite journal | vauthors = Bartfai T, Conti B | title = Fever | journal = TheScientificWorldJournal | volume = 10 | pages = 490–503 | date = March 2010 | pmid = 20305990 | pmc = 2850202 | doi = 10.1100/tsw.2010.50 | doi-access = free }}</ref> Although aspirin's use as an [[antipyretic]] in adults is well established, many medical societies and regulatory agencies, including the [[American Academy of Family Physicians]], the [[American Academy of Pediatrics]], and the [[Food and Drug Administration]], strongly advise against using aspirin for the treatment of fever in children because of the risk of [[Reye's syndrome]], a rare but often fatal illness associated with the use of aspirin or other salicylates in children during episodes of viral or bacterial infection.<ref>{{cite journal | vauthors = Pugliese A, Beltramo T, Torre D | title = Reye's and Reye's-like syndromes | journal = Cell Biochemistry and Function | volume = 26 | issue = 7 | pages = 741–6 | date = October 2008 | pmid = 18711704 | doi = 10.1002/cbf.1465 | s2cid = 22361194 }}</ref><ref>{{cite journal | vauthors = Beutler AI, Chesnut GT, Mattingly JC, Jamieson B | title = FPIN's Clinical Inquiries. Aspirin use in children for fever or viral syndromes | journal = American Family Physician | volume = 80 | issue = 12 | pages = 1472 | date = December 2009 | pmid = 20000310 }}</ref><ref name=AAPweb>{{cite web|title=Medications Used to Treat Fever|date=29 June 2012 |url=http://www.healthychildren.org/English/health-issues/conditions/fever/Pages/Medications-Used-to-Treat-Fever.aspx|publisher=American Academy of Pediatrics|access-date=25 November 2012|url-status=live|archive-url=https://web.archive.org/web/20130218084054/http://www.healthychildren.org/English/health-issues/conditions/fever/Pages/Medications-Used-to-Treat-Fever.aspx|archive-date=18 February 2013}}</ref> Because of the risk of Reye's syndrome in children, in 1986, the US [[Food and Drug Administration]] (FDA) required labeling on all aspirin-containing medications advising against its use in children and teenagers.<ref name="FDA 1986 FR">{{cite journal|title=51 FR 8180|url=https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/UCM078593.pdf|journal=United States Federal Register|volume=51|issue=45|date=7 March 1986|url-status=dead|archive-url=https://web.archive.org/web/20110819130409/https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/UCM078593.pdf|archive-date=19 August 2011}}</ref>
 
===Inflammation===
Line 380 ⟶ 382:
 
=== In gardening ===
There are many anecdotal reportings that aspirin can improve plant's growth and resistance<ref>{{cite web |title=Aspirin Water Helps Plants |url=https://cybercemetery.unt.edu/archive/allcollections/20090117082434/http://www.plantea.com/plant-aspirin.htm |access-date= |website=cybercemetery.unt.edu}}</ref><ref>{{cite web |title=Gardens: drug therapy for plants {{!}} Gardening advice |url=https://amp.theguardian.com/lifeandstyle/2016/jan/31/drug-therapy-for-plants |access-date= |website=[[The Guardian]]|date=31 January 2016 }}</ref> though most research involved [[salicylic acid]] instead of aspirin.<ref>{{cite web |title=Priming Plant Defenses with Aspirin-like Compound : USDA ARS |url=https://www.ars.usda.gov/news-events/news/research-news/2014/priming-plant-defenses-with-aspirin-like-compound/ |access-date= |website=www.ars.usda.gov}}</ref>
 
== Veterinary medicine ==
Line 396 ⟶ 398:
* {{cite journal | vauthors = McTavish JR | title = What's in a name? Aspirin and the American Medical Association | journal = Bulletin of the History of Medicine | volume = 61 | issue = 3 | pages = 343–66 | date = 1987 | pmid = 3311247 | doi = | jstor = 44442097 }}
* {{cite encyclopedia |vauthors=Ling G |title=Aspirin |url=http://www.madehow.com/Volume-1/Aspirin.html |encyclopedia=How Products Are Made |volume=1 |publisher=Thomson Gale |year=2005}}
*{{cite book|title= Aspirin: the Remarkable Story of a Wonder Drug |author= Diarmuid Jeffreys |publisher=Bloomsbury |date=2004 }}
{{refend}}
 
== External links ==
*{{Commonscat-inline}}
{{Commons}}
 
{{ATC navboxes|B01|D10|M01A|N02A}}